Zinc should be part of any balanced diet, but it also regulates signals in your brain.
It’s been found to play a critical role in coordinating communication between cells in the brain, possibly governing the formation of memories and controlling the occurrence of epileptic seizures.
For many, high sugar intake can cause seizures…along with emotional instability…dizziness…depression…food allergies…diabetes…and osteoporosis…to name just a few.
Even worse, aspartame interacts with anti-seizure medication.
And over the years, various reports have implicated aspartame in headaches, memory loss, seizures, vision loss, coma, and cancer.
It also appears to worsen or mimic the symptoms of such conditions as fibromyalgia, MS, lupus, diabetes, Alzheimer’s, chronic fatigue, and depression.
And, after receiving some 10,000 consumer complaints, the FDA compiled a list of 92 symptoms linked to aspartame — including death.
But there are two healthy alternatives…
You probably already know a lot about all the benefits of Omega-3 fatty acids. About how they are crucial to the proper development and function of cell membranes in the brain.
And how, according to researchers at Emory University, one particular fatty acid – DHA — is found to be at critically low levels in patients with uncontrolled epilepsy. Which is why doctors recommend diets rich in Omega-3.
However, there’s a new nutrient that’s BIGGER and better…
Researchers have found that inducing a biochemical alteration in brain proteins via the dietary supplement glucosamine was able to rapidly dampen that pathological hyperexcitability in rat and mouse models.
These results represent a potentially novel therapeutic target for the treatment of seizure disorders, and they show the need to better understand the physiology underlying these neural and brain circuit changes.
Seizure disorders — including epilepsy — are associated with pathological hyperexcitability in brain neurons.
Cell transplantation is an emerging approach for treating drug resistant epilepsy.
Regenerative medicine such as this, is a relatively “simple” process in that stem cells are often cultured from the patient’s own tissue, then processed and transfused back into the body.
A newly-released report from Pharmaceutical Research and Manufacturers of America (PhRMA) has revealed that 28 new medications are in development to treat epilepsy and seizures.
But that’s just the tip of the iceberg.
These 28 new drugs are among nearly 420 new ground-breaking medicines in progress to treat neurological disorders.
There’s a whole treasure trove of clinical trials information now available as a free service of the National Institutes of Health, developed by the National Library of Medicine (NLM).
ClinicalTrials.gov is a web-based resource that provides patients, family members, health care professionals, researchers, and the public with easy access to information on publicly and privately supported clinical studies on a wide range of diseases and conditions.
Presently, there are 131,167 studies with locations in 179 countries, including the U.S. Studies are easy to search for by topic and location.
New therapies, including medications, medical devices and surgical procedures, are evaluated in research studies known as clinical trials.
Often these new therapies are investigational, which means they are not yet approved by the U.S. Food and Drug Administration for general use.
Participation in clinical trials offers the potential for new treatment options and allows patients to participate with researchers in driving the discovery of effective therapies for epilepsy…
Recently, the FDA approved the very first 3D-printed medication.
3D printing has taken the world by storm, and although it may sound like science fiction, it’s here to stay.
And the pharmaceutical industry is getting in on this innovative technology.